|
|
||||||||
Clinic of Neurology, Department of Biochemical Pharmacology, and Clinic of Neurosurgery, University of Vienna, Vienna, Austria
Correspondence: For reprints contact: Erhard Suess, MD, Clinic of Neurology, University of Vienna, Lazarettgasse 14, A-1090 Vienna, Austria.
ABSTRACT
Technetium-d, HMPAO SPECT was performed in 70 patients suffering from intracerebral tumors of various histologic types (glioma n = 30, meningeoma n = 19, metastases n = 10, angioma n = 3, neuroma n = 2, lymphoma n = 2, neurocytoma n = 1, epidermoid n = 1, gliosis n = 1, cholesteatoma n = 1). Tumor classification was histologically verified in all subjects except in two cases with inoperable angiomas. SPECT was performed under resting state conditions with a dual-head rotating camera (SIEMENS ZLC 37) following intravenous injection of 1825 mCi 99mTc-d, 1-HMPAO. Regional tracer deposit was expressed in terms of a cerebellar index (CBI). Significantly higher regional HMPAO uptake was found in meningeomas when compared with gliomas of different malignancy (ANOVA p < 0.05). Within gliomas, regional uptake increased with malignancy (n.s.). In 23 patients, a total of 32 tumor specimens were obtained for histochemical analysis of glutathione (GSH) content using high-pressure liquid chromatography. A significant correlation (least square method, p < 0.001) between CBIs and GSH values was found, supporting the hypothesis that GSH is the predominant factor for the conversion of the lipophilic complex to hydrophilic derivates.
This article has been cited by other articles:
![]() |
B. Wilczek, L. Svensson, R. Danielsson, F. Celebiouglu, S. A. Larsson, and H. Jacobsson 99mTc-Exametazime as a Breast Tumor-Seeking Agent: Comparison with 99mTc-Sestamibi J. Nucl. Med., December 1, 2004; 45(12): 2040 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sagiuchi, K. Ishii, S. Utsuki, Y. Asano, S. Tsukahara, S. Kan, K. Fujii, and K. Hayakawa Increased Uptake of Technetium-99m-Hexamethylpropyleneamine Oxime Related to Primary Leptomeningeal Melanoma AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1404 - 1406. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |